Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed May 10, 2017 · 10-Q · 40 days after period end · 0001615774-17-002182
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$1.55M | -$2.03M | -$1.72M | -$1.02M |
| EPS Diluted | -$0.04 | -$0.06 | -$0.12 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 10, 2017 · 40 d after period end
